B
Composite 6.8 / 10
Last updated 2026-04-29. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Editorial summary
14 peptides covered with 58 lab tests. BPC-157 averages 6.6 across 6 tests with consistency penalty triggered.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| Ipamorelin | 7.2B |
7.2 | 4 | 98.5% | — | — | 2026-04-12 | view |
| GHK-Cu | 6.5B |
6.5 | 5 | 98.3% | — | — | 2026-04-12 | view |
| BPC-157 | 6.4B |
6.4 | 6 | 98.8% | — | $1.10 | 2026-03-04 | view |
| Semaglutide | 6.4B |
6.4 | 5 | 98.4% | — | — | 2026-04-12 | view |
COA transparency
- ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
- ○ Both HPLC and mass spec shown (pending)
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ✓ Most recent COA within 90 days (2026-04-12)
Pricing
| Peptide | List $/mg | Verified $/mg | Market median | vs market |
|---|---|---|---|---|
| BPC-157 | $— | $1.10 | $0.95 | +16% |
All vendor grades, side-by-side
Compare Limitless Life Nootropics against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.